Biocon has announced that the U.S. Food and Drug Administration (US FDA) has concluded an inspection with two observations at ...
The Central Drugs Standard Control Organisation (CDSCO) has ordered state drug controllers to conduct thorough inspections of all pharmaceutical manufacturing units to ensure compliance with ...
The one-year grace period for MSME drug manufacturers to comply with revised Schedule M norms has ended, with the CDSCO ...
In a bid to enforce Good Manufacturing Practices (GMP) at drug manufacturing companies, India’s drug regulator has asked all ...
1d
Drug Regulator Calls Schedule M Adoption ‘Top Priority’, Orders Immediate Inspections Across India
Schedule M lays down India’s Good Manufacturing Practice standards for medicines. CDSCO has ordered states and UTs to begin immediate inspections to ensure compliance ...
With regulatory agencies like the FDA, EMA, and MHRA intensifying data integrity compliance, significant market opportunities exist in providing robust data management solutions. Organizations can ...
Opportunities arise in training and certifying GMP auditors, focusing on developing strong communication, observational skills, and professional auditing techniques. The program offers a comprehensive ...
The 8-page report listed six major observations, concluding that the warehouse was operating outside fundamental Good ...
Shardul Nautiyal, Mumbai Thursday, October 30, 2025, 08:00 Hrs [IST] ...
Wild Child Laboratories was flagged by the FDA multiple times in recent years for breaching manufacturing standards.
An Australian manufacturer at the centre of the sunscreen scandal repeatedly failed to follow manufacturing standards during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback